CINECA IRIS Institutional Research Information System
IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi di Torino.
AperTO è l'archivio istituzionale Open Access destinato a raccogliere, rendere visibile e conservare la produzione scientifica dell'Università degli Studi di Torino.
ItalianoKARAMOUZIS, IOANNIS
Dettaglio
KARAMOUZIS, IOANNIS
SCIENZE MEDICHE
Pubblicazioni
Risultati 1 - 20 di 23 (tempo di esecuzione: 0.001 secondi).
| Titolo | Data di pubblicazione | Autore(i) | |
|---|---|---|---|
| 1 | ACUTE ADMINISTRATION OF ALPRAZOLAM, A BENZODIAZEPINE ACTIVATING GABA RECEPTORS, INHIBITS CORTISOL SECRETION IN PATIENTS WITH SUBCLINICAL BUT NOT OVERT CUSHING'S SYNDROME | 2013 | R. Giordano; R. Berardelli; I. Karamouzis; V. D’Angelo; A. Picu; C. Zichi.; B. Fussotto; M. Manzo; G. Mengozzi; E. Ghigo; E. Arvat |
| 2 | THE ACUTE EFFECT OF A MINERALOCORTICOID RECEPTOR AGONIST ON CORTICOTROPE SECRETION IN ADDISON'S DISEASE | 2016 | Berardelli, R.; Karamouzis, I.; D'Angelo, V.; Fussotto, B.; Minetto, M.A.; Ghigo, E.; Giordano, R.; Arvat, E. |
| 3 | *ASSESSMENT OF BONE BIOCHEMICAL INDICATORS IN THALASSAEMIA AND SICKLE CELL ANEMIA* | 2010 | *K.Thisiadou;I.Karamouzis;S.Arampatzi;M.Karamouzis.* |
| 4 | BCLI POLYMORPHISM OF THE GLUCOCORTICOID RECEPTOR GENE IS ASSOCIATED WITH INCREASED OBESITY, IMPAIRED GLUCOSE TOLERANCE AND DYSLIPIDEMIA IN PATIENTS WITH ADDISON’S DISEASE | 2012 | R. Giordano; S. Marzotti; R. Berardelli; I. Karamouzis; A. Brozzetti; V. D’Angelo; G. Mengozzi; G. Mandrile; D. Giachino; G. Migliaretti; V. Bini; A. Falorni; E. Ghigo; E. Arvat |
| 5 | *Calcium-phosphorus metabolism and parathyroid function in patients with end stage chronic kidney disease* | 2010 | *I.Karamouzis ;K.Thisiadou;S.Arampatzi;D.Michailidou* |
| 6 | CUSHING'S SYNDROME IS ASSOCIATED WITH SLEEP ALTERATIONS DETECTED BY WRIST ACTIGRAPHY | 2015 | D'Angelo, V; Beccuti, G; Berardelli, R; Karamouzis, I; Zichi, C; Giordano, R; Minetto, Ma; Maccario, M; Ghigo, E; Arvat, E |
| 7 | DUAL-RELEASE HYDROCORTISONE IN ADDISON’S DISEASE-A REVIEW OF THE LITERATURE | 2014 | R. Giordano; F. Guaraldi; R. Berardelli; I Karamouzis; V. D’Angelo; C. Zichi; S. Grottoli; E. Ghigo; E. Arvat |
| 8 | Effect of acute and prolonged mineralocorticoid receptor blockade on spontaneous and stimulated hypothalamus-pituitary-adrenal (HPA) axis in humans | 2010 | R. Berardelli; I. Karamouzis; E. Marinazzo; E. Prats; A. Picu; R. Giordano; E. Ghigo; E. Arvat |
| 9 | The effect of different exercise-testing protocols on atrial natriuretic peptide | 2011 | *Mandroukas A; Metaxas TI; Heller J; Vamvakoudis E; Christoulas K; Riganas CS; Sendelides T; Stefanidis P; Kotoglou K; Karamouzis I; Mandroukas K* |
| 10 | EFFECT OF PROLONGED TREATMENT WITH POTASSIUM CANRENOATE, A MR ANTAGONIST, ON BASAL AND STIMULATED HYPOTHALAMUS-PITUITARY-ADRENAL (HPA) AXIS IN HUMANS | 2009 | R. Berardelli; E. Marinazzo; E. Prats; A. Picu; R. Giordano; I. Karamouzis; E. Ghigo; E Arvat |
| 11 | EFFECTS OF CETRORELIX, A GnRH-RECEPTOR ANTAGONIST, ON GONADAL AXIS IN WOMEN WITH FUNCTIONAL HYPOTHALAMIC AMENORRHEA | 2011 | R. Berardelli; L. Gianotti; I. Karamouzis; A. Picu; R. Giordano; V. D'Angelo; D. Zinnà; F. Lanfranco; E. Ghigo; E. Arvat |
| 12 | Enhanced oxidative stress and platelet activation in patients with Cushing's syndrome. | 2015 | I. Karamouzis; R. Berardelli; V. D'Angelo; B. Fussotto; C. Zichi; R. Giordano; F. Settanni; M. Maccario; E. Ghigo; E. Arvat |
| 13 | GLUCOCORTICOID RECEPTOR POLYMORPHISMS AND METABOLIC-CARDIOVASCULAR PROFILE IN PATIENTS WITH ADDISON’S DISEASE UNDER REPLACEMENT THERAPY | 2011 | R. Giordano; S. Marzotti; R. Berardelli; I. Karamouzis; E. Marinazzo; A. Picu; D. Forno; D. Zinnà; D. Giachino; A. Falorni; E. Ghigo; E. Arvat |
| 14 | IMPROVEMENT OF ANTHROPOMETRIC AND METABOLIC PARAMETERS, AND QUALITY OF LIFE FOLLOWING TREATMENT WITH DUAL-RELEASE HYDROCORTISONE IN PATIENTS WITH ADDISON'S DISEASE | 2016 | Giordano, R; Guaraldi, F; Marinazzo, E; Fumarola, F; Rampino, A; Berardelli, R; Karamouzis, I; Lucchiari, M; Manetta, T; Mengozzi, G; Arvat, E; Ghigo, E |
| 15 | METABOLIC AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT AETIOLOGY DURING ACTIVE DISEASE AND 1 YEAR AFTER REMISSION | 2011 | R. Giordano; A. Picu; E. Marinazzo; V. D'Angelo; R. Berardelli; I. Karamouzis; D.Forno; D. Zinnà; M. Maccario; E. Ghigo; E. Arvat |
| 16 | METABOLIC AND CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT ETIOLOGY BEFORE AND 1 YEAR AFTER DISEASE REMISSION | 2010 | A. Picu; E. Marinazzo; M. Balbo; R. Berardelli; I. Karamouzis; E. Ghigo; R. Giordano; E. Arvat |
| 17 | Neuroendocrine effects of citalopram, a selective serotonine re-uptake inhibitor, during life span in humans | 2010 | R. Berardelli; E. Margarito; F. Ghiggia; A. Picu; M. Balbo; L. Bonelli; R. Giordano; I. Karamouzis; M. Bo; E. Ghigo; E. Arvat |
| 18 | Retrospective observational analysis of non-irradiated non-functioning pituitary adenomas | 2015 | Karamouzis, I; Berardelli, R.; Prencipe, N.; Berton, A.; Bona, C.; Stura, G.; Corsico, M.; Gasco, V.; Maccario, M.; Ghigo, E.; Grottoli, S. |
| 19 | ROLE OF MINERALOCORTICOID RECEPTORS ON HPA AXIS IN HUMANS | 2013 | R. Berardelli; I. Karamouzis; V. D’Angelo; C. Zichi; B. Fussotto; R. Giordano; E.Ghigo; E. Arvat |
| 20 | Secondary adrenal insufficiency: Where is it hidden and what does it look like? | 2016 | Guaraldi, Federica; Karamouzis, Ioannis; Berardelli, Rita; D'Angelo, Valentina; Rampino, Alessia; Zichi, Clizia; Ghigo, Ezio; Giordano, Roberta |
Copyright © 2022